As we revealed the interplay of various cell types including colonocytes and cycling cells in CEACAM1_CEACAM5 interaction in IBD or colorectal cancer patients, it might highlight targeting these cells to reverse the adverse conditions. Here, CEACAM5 is linked to inflammatory bowel disease.